Total Payments
$340,843
2024 Payments
$45,530
Companies
17
Transactions
417
Medicare Patients
13,641
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$300,172 (88.1%)
Food & Beverage$17,409 (5.1%)
Travel$15,088 (4.4%)
Consulting$8,067 (2.4%)
Education$107.58 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300,172 | 122 | 88.1% |
| Food and Beverage | $17,409 | 212 | 5.1% |
| Travel and Lodging | $15,088 | 71 | 4.4% |
| Consulting Fee | $8,067 | 9 | 2.4% |
| Education | $107.58 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $224,353 | 188 | $0 (2024) |
| Lilly USA, LLC | $41,699 | 42 | $0 (2024) |
| Amgen Inc. | $30,187 | 55 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $20,249 | 27 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $12,635 | 9 | $0 (2019) |
| PFIZER INC. | $6,792 | 22 | $0 (2019) |
| BIOTRONIK INC. | $2,139 | 34 | $0 (2024) |
| Abbott Laboratories | $1,191 | 10 | $0 (2023) |
| Medtronic Vascular, Inc. | $603.02 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $543.33 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,530 | 55 | Boehringer Ingelheim Pharmaceuticals, Inc. ($23,093) |
| 2023 | $36,151 | 37 | Boehringer Ingelheim Pharmaceuticals, Inc. ($32,048) |
| 2022 | $49,840 | 47 | Boehringer Ingelheim Pharmaceuticals, Inc. ($41,491) |
| 2021 | $39,786 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28,706) |
| 2020 | $37,406 | 42 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21,195) |
| 2019 | $59,887 | 80 | Boehringer Ingelheim Pharmaceuticals, Inc. ($29,768) |
| 2018 | $41,517 | 55 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28,560) |
| 2017 | $30,727 | 49 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,493) |
All Payment Transactions
417 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $91.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $887.95 | General |
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $98.45 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $459.40 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $421.59 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.22 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Terumo Medical Corporation | ANGIO-SEAL (Device) | Food and Beverage | In-kind items and services | $36.09 | General |
| Category: VASCULAR ACCESS | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $374.32 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $111.47 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $28.16 | General |
| Category: Coronary | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $86.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.97 | General |
| Category: Cardiovascular | ||||||
| 07/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2024 | Terumo Medical Corporation | TR BAND (Device), ANGIO-SEAL | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: VASCULAR ACCESS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,308 | 4,973 | $2.0M | $484,149 |
| 2022 | 20 | 3,378 | 4,961 | $2.0M | $446,446 |
| 2021 | 21 | 3,600 | 5,078 | $2.6M | $457,587 |
| 2020 | 22 | 3,355 | 4,795 | $2.9M | $364,566 |
Total Patients
13,641
Total Services
19,807
Medicare Billing
$1.8M
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 698 | 1,335 | $574,050 | $147,760 | 25.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 525 | 531 | $493,830 | $96,508 | 19.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 104 | 208 | $95,680 | $72,195 | 75.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 107 | 107 | $212,930 | $45,840 | 21.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 255 | 256 | $220,160 | $44,949 | 20.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 732 | 1,287 | $154,440 | $16,468 | 10.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 69 | 69 | $57,270 | $13,358 | 23.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 69 | $40,020 | $11,479 | 28.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 107 | 107 | $33,170 | $6,232 | 18.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 34 | 136 | $52,224 | $6,170 | 11.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 402 | 580 | $8,700 | $4,831 | 55.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 43 | $12,470 | $3,481 | 27.9% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 21 | 37 | $13,320 | $3,416 | 25.6% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 24 | 58 | $8,700 | $2,546 | 29.3% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 17 | 26 | $8,320 | $2,288 | 27.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 27 | 27 | $3,105 | $2,047 | 65.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 20 | 27 | $6,480 | $1,946 | 30.0% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 14 | 17 | $4,590 | $1,265 | 27.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $2,160 | $971.46 | 45.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 12 | 13 | $1,430 | $201.16 | 14.1% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 12 | 13 | $1,560 | $196.63 | 12.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 642 | 1,154 | $496,220 | $131,804 | 26.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 521 | 524 | $487,320 | $96,433 | 19.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 130 | 130 | $258,700 | $57,442 | 22.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 257 | 262 | $225,320 | $45,665 | 20.3% |
About Dr. Steven Shayani, MD
Dr. Steven Shayani, MD is a Cardiovascular Disease healthcare provider based in Carle Place, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306824008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Shayani, MD has received a total of $340,843 in payments from pharmaceutical and medical device companies, with $45,530 received in 2024. These payments were reported across 417 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($300,172).
As a Medicare-enrolled provider, Shayani has provided services to 13,641 Medicare beneficiaries, totaling 19,807 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Carle Place, NY
- Active Since 01/04/2006
- Last Updated 04/14/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1306824008
Products in Payments
- JARDIANCE (Drug) $249,913
- Repatha (Biological) $29,276
- PRALUENT ALIROCUMAB INJECTION (Biological) $15,742
- PRADAXA (Drug) $13,966
- PRALUENT (Drug) $12,635
- ELIQUIS (Drug) $6,794
- PRALUENT (Biological) $4,507
- XARELTO (Drug) $543.33
- Mitra Clip system (Device) $369.49
- AMVIA EDGE (Device) $233.46
- Acticor 7 VR-T DX (Device) $203.25
- CoreValve Evolut (Device) $179.80
- PRESSUREWIRE (Device) $174.39
- Edora (Device) $152.17
- Circulatory Support (Device) $142.98
- HeartMate (Device) $142.09
- CARDIOMEMS (Device) $141.07
- Micra (Device) $139.01
- CardioInsight (Device) $138.75
- Amplia MRI (Device) $131.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.